Chitosan-sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents.

IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Future medicinal chemistry Pub Date : 2024-04-01 Epub Date: 2024-02-22 DOI:10.4155/fmc-2023-0351
Abdullah Ya Alzahrani, Sobhi M Gomha, Magdi Ea Zaki, Basant Farag, Fathy E Abdelgawad, Mahmoud A Mohamed
{"title":"Chitosan-sulfonic acid-catalyzed green synthesis of naphthalene-based azines as potential anticancer agents.","authors":"Abdullah Ya Alzahrani, Sobhi M Gomha, Magdi Ea Zaki, Basant Farag, Fathy E Abdelgawad, Mahmoud A Mohamed","doi":"10.4155/fmc-2023-0351","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> This study focuses on advancing green chemistry in anticancer drug discovery, particularly through the synthesis of azine derivatives with a naphthalene core using CS-SO<sub>3</sub>H as a catalyst. <b>Methods:</b> Novel benzaldazine and ketazine derivatives were synthesized using (<i>E</i>)-(naphthalen-1-ylmethylene)hydrazine and various carbonyl compounds. The methods employed included thermal and grinding techniques, utilizing CS-SO<sub>3</sub>H as an eco-friendly and cost-effective catalyst. <b>Results:</b> The approach resulted in high yields, short reaction times and demonstrated catalyst reusability. Cytotoxicity tests highlighted compounds <b>3b, 11</b> and <b>13</b> as potent against the HEPG2-1. <b>Conclusion:</b> This study successfully aligns with the objectives of eco-conscious drug development in organic chemistry. Molecular docking and <i>in silico</i> studies further indicate the potential of these ligands as antitumor medicines, with favorable oral bioavailability properties.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":" ","pages":"647-663"},"PeriodicalIF":3.2000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4155/fmc-2023-0351","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: This study focuses on advancing green chemistry in anticancer drug discovery, particularly through the synthesis of azine derivatives with a naphthalene core using CS-SO3H as a catalyst. Methods: Novel benzaldazine and ketazine derivatives were synthesized using (E)-(naphthalen-1-ylmethylene)hydrazine and various carbonyl compounds. The methods employed included thermal and grinding techniques, utilizing CS-SO3H as an eco-friendly and cost-effective catalyst. Results: The approach resulted in high yields, short reaction times and demonstrated catalyst reusability. Cytotoxicity tests highlighted compounds 3b, 11 and 13 as potent against the HEPG2-1. Conclusion: This study successfully aligns with the objectives of eco-conscious drug development in organic chemistry. Molecular docking and in silico studies further indicate the potential of these ligands as antitumor medicines, with favorable oral bioavailability properties.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
壳聚糖-磺酸催化的萘醌类潜在抗癌剂的绿色合成。
目的:本研究的重点是推进抗癌药物研发中的绿色化学,尤其是以 CS-SO3H 为催化剂合成以萘为核心的嗪衍生物。研究方法使用 (E)-(萘-1-基亚甲基)肼和各种羰基化合物合成了新型苯并咪唑和酮嗪衍生物。所采用的方法包括热技术和研磨技术,并利用 CS-SO3H 作为一种环保且具有成本效益的催化剂。结果:该方法产率高,反应时间短,催化剂可重复使用。细胞毒性测试表明,化合物 3b、11 和 13 对 HEPG2-1 具有很强的毒性。结论本研究成功地实现了有机化学中具有生态意识的药物开发目标。分子对接和硅学研究进一步表明了这些配体作为抗肿瘤药物的潜力,并具有良好的口服生物利用度特性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Future medicinal chemistry
Future medicinal chemistry CHEMISTRY, MEDICINAL-
CiteScore
5.80
自引率
2.40%
发文量
118
审稿时长
4-8 weeks
期刊介绍: Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.
期刊最新文献
A comprehensive review on the latest advances of dimeric anticancer prodrugs. A comprehensive insight into naphthalimides as novel structural skeleton of multitargeting promising antibiotics. A call to develop tramadol enantiomer for overcoming the tramadol crisis by reducing addiction. Advancements in PROTAC-based therapies for neurodegenerative diseases. EGFR molecular degraders: preclinical successes and the road ahead.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1